CLPT

ClearPoint Neuro, Inc. (NASDAQ:CLPT) is a medical device company founded in 1998 and headquartered in Solana Beach, California. Originally incorporated as MRI Interventions, Inc., the company changed its name to ClearPoint Neuro in February 2020 to better reflect its focus on neurological applications. The company specializes in developing and commercializing platforms that enable minimally invasive surgical procedures in the brain under direct, real-time magnetic resonance imaging (MRI) guidance. ClearPoint has established itself as a key enabler in the emerging cell and gene therapy market while also serving traditional neurosurgery applications.